Letters to the Editor

Tyrosine kinase inhibitor discontinuation in non-allografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life study

Hematology and Cellular Therapy, IRCCS Ospedale Policlinico San Martino
Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome
Istituto di Ematologia “Seràgnoli”, IRCCS Azienda Ospedaliero-Universitaria di Bologna
Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milano
Dipartimento di Medicina e Chirurgia, Università di Perugia, Ospedale "Santa Maria della Misericordia", Perugia
UOC Ematologia, Azienda Ospedaliera San Giovanni Addolorata
Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genova
Department of Hematology, Polo Universitario Pontino, S.M. Goretti Hospital, Latina
Department of Hematology, Ospedale Civile Spirito Santo, Pescara
Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milan, Italy; Hematology Division, Busto Arsizio Hospital, ASST Valleolona, Varese
Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome
Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome
Haematologica Early view Jan 9, 2025 https://doi.org/10.3324/haematol.2024.286325